Methotrexate 2.5 mg TID is INCORRECT and DANGEROUS
Methotrexate 2.5 mg three times daily (tid) represents a critical medication error that can lead to life-threatening toxicity, including bone marrow suppression, hepatotoxicity, and death. Methotrexate for psoriasis and rheumatoid arthritis must be dosed WEEKLY, not daily.
The Critical Error
Daily dosing of methotrexate 2.5 mg (which tid would represent) has been directly compared to weekly dosing and showed LESS efficacy, MORE liver enzyme elevations, and is NOT the standard of care 1.
A documented case report describes a patient who mistakenly took methotrexate 2.5 mg daily instead of 2.5 mg three times weekly, resulting in severe toxicity with painful ulcers, difficulty swallowing, cutaneous lesions, acute renal failure, and requiring hospitalization with leucovorin rescue 2.
The FDA label and multiple guidelines explicitly warn that mistaken daily use of the recommended weekly dose has led to fatal toxicity 3.
Correct Dosing for Psoriasis
Methotrexate for psoriasis should be administered as 7.5-25 mg WEEKLY, given either as a single dose or divided into 3 doses over 24 hours (not 3 times daily) 1.
Specific Dosing Recommendations:
Starting dose: 10-15 mg weekly, with some clinicians using a test dose of 2.5-5 mg initially in high-risk patients 1.
Split-dosing option: When the weekly dose is divided, it should be given as 3 doses every 8-12 hours over a 24-hour period ONCE per week, not three times daily 1.
Dose escalation: Increase by 5 mg every 2-4 weeks up to 20-30 mg weekly based on response and tolerability 1.
Why Weekly Dosing?
Weekly dosing (15 mg divided into 3 doses every 8 hours over 24 hours once weekly) demonstrated superior efficacy compared to daily dosing (2.5 mg daily for 6 days/week) 1.
Daily dosing was associated with higher rates of liver enzyme elevation 1.
The mechanism of action involves immunosuppression through decreased lymphoid cell proliferation, which is optimally achieved with weekly dosing 1.
Essential Safety Measures
If a patient has been taking methotrexate 2.5 mg tid (three times daily), this constitutes a medical emergency requiring:
Immediate discontinuation of methotrexate 2.
Urgent laboratory evaluation: CBC with differential, liver function tests, renal function 3, 2.
Consider leucovorin rescue: 15 mg IV or orally every 6 hours if significant toxicity is present 3, 2.
Close monitoring for signs of bone marrow suppression (fever, bleeding, bruising), hepatotoxicity (nausea, abdominal pain, dark urine), and mucositis 3, 2.
Mandatory Folic Acid Supplementation
Folic acid 5 mg weekly (or 1 mg daily) should be prescribed with methotrexate, given on days when methotrexate is NOT taken 1.
This reduces gastrointestinal and hepatic adverse effects without compromising efficacy 1.
Common Pitfall to Avoid
The most dangerous error is confusing "2.5 mg three times weekly" with "2.5 mg three times daily." Prescriptions should clearly state the WEEKLY total dose and specify the exact days of administration to prevent this potentially fatal mistake 3, 2.